Literature DB >> 8443468

Complement activation and C3 allotype distribution in patients with bronchial asthma.

M Kirschfink1, F F Castro, U Rother, J A Nakhosteen, R Deppisch, M Schmitz-Schumann.   

Abstract

61 patients suffering from intrinsic (idiotypic) or extrinsic (allergic) asthma were investigated for signs of complement activation and for C3 phenotype distribution. Activation of both the classical and alternative pathway of the complement system and generation of the membrane attack complex could be assessed by ELISAs for the activation-specific protein-protein complexes C1rsC1 inhibitor, C3b(Bb)P and SC5b-9, respectively. A possible deficiency of the complement regulatory proteins C1 inhibitor, factor H and factor I was excluded. In contrast to earlier studies, C3 allele frequencies did not differ from those found in the healthy population. Our results support the role of complement activation during bronchial asthma and, thereby, provide further evidence for the inflammatory nature of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443468     DOI: 10.1159/000236402

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  3 in total

1.  Complement components (C3, C4) in childhood asthma.

Authors:  F I E Najam; A S M Giasuddin; A H Shembesh
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

Review 2.  Clinical utility of complement assessment.

Authors:  A E Ahmed; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

3.  Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL.

Authors:  S Kaur; V K Gupta; A Shah; S Thiel; P U Sarma; T Madan
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.